September 21, 2017 6:04 AM ET

Life Sciences Tools and Services

Company Overview of Pall ForteBio LLC

Key Executives for Pall ForteBio LLC

NameBoard RelationshipsTitleAge
Joseph D. Keegan Ph.D.71 RelationshipsChief Executive Officer, President and Director63
Robert Wicke No RelationshipsVice President of Product Development & Operations and General Manager47
Lei Wu Ph.D.No RelationshipsVice President of China Operations--
Kenneth J. Kelley MBA20 RelationshipsExecutive Officer58
Christopher M. Silva No RelationshipsVice President of Marketing--

Pall ForteBio LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Joseph D. Keegan Ph.D. 71 RelationshipsPall ForteBio LLC63
Craig C. Taylor 115 RelationshipsAlloy Ventures, Inc.67
James N. Woody M.D., Ph.D. 29 RelationshipsAvidia, Inc.75
Yue-Teh Jang Ph.D. 5 RelationshipsMedeon Biodesign, Inc.--
Timothy A. Harkness 20 RelationshipsUnchained Labs Inc.50
View All Board Members

Pall ForteBio LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
414.2K
Bonus
211.4K
Total Short Term Compensation
481.7K
Total Value of Options
19.9M
Compensation as of Fiscal Year
Pall ForteBio LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Abzena plc Appoints Lotta Ljungqvist as Non-Executive Director
September 19, 2017 6:00 AM ET
ResearchPoint Global Expands Executive Management Team
September 18, 2017 2:17 PM ET
Arcus Biosciences Appoints Kate Falberg to its Board of Directors
September 18, 2017 12:00 PM ET
PerkinElmer Announces Retirement of Andy Wilson as Senior Vice President and Chief Financial Officer
September 15, 2017 8:15 PM ET
Modus Therapeutics AB Appoints Dr. Thomas Knittel as Chief Medical Officer
September 14, 2017 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pall ForteBio LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.